Functions and mechanisms of action of the adenovirus E3 proteins.
about
Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibitionThe adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome.Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model.A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands.Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster modelA phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumorsHost range, prevalence, and genetic diversity of adenoviruses in batsAdipocyte inflammation is essential for healthy adipose tissue expansion and remodelingConstruction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains.Comparison of human memory CD8 T cell responses to adenoviral early and late proteins in peripheral blood and lymphoid tissue.Adenovirus infections in immunocompetent and immunocompromised patients.Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genomeInterference with intraepithelial TNF-α signaling inhibits CD8(+) T-cell-mediated lung injury in influenza infectionNo evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection.Dose dependent activation of retinoic acid-inducible gene-I promotes both proliferation and apoptosis signals in human head and neck squamous cell carcinoma.Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of doseIncreasing the efficacy of oncolytic adenovirus vectorsStrong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission.Adenovirus RIDalpha regulates endosome maturation by mimicking GTP-Rab7.Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAILA fully replication-competent adenovirus vector with enhanced oncolytic propertiesImmunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.Viruses - seeking and destroying the tumor program.Inactivating intracellular antiviral responses during adenovirus infection.Gene therapy for malignant mesothelioma: beyond the infant years.Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers.Long story short: p53 mediates innate immunity.Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters.Latent species C adenoviruses in human tonsil tissues.Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac.The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster modelThe role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors.Homologous recombination in E3 genes of human adenovirus species DAdenoviruses in immunocompromised hostsCross-regulation between herpesviruses and the TNF superfamily membersTRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5Adenoviral vector-based strategies for cancer therapy.
P2860
Q24682546-44C8AFF0-E342-438F-87C2-34E57296C430Q30415541-7F625E90-3C5C-4DBA-B5B7-E65CE25208B3Q30525107-6C44B766-EFCA-4C25-A5C5-633227AAD19FQ33586270-1A8FCDCD-93F5-40CD-A1F6-B1533BCC89F2Q33713048-6A61C410-15BB-4DD9-8E5E-77B99FE4B7A3Q33730735-A76A8B27-3671-46EE-9E40-E6D778B74578Q33769343-77C08E64-9AAF-435D-AAC8-9AF80B251CCFQ33838623-56909F81-C248-4231-B256-501BD2B81513Q33872445-ADFFCC4D-538F-449F-BE75-E4E42AF494B9Q33921073-FA161F59-7A68-40C8-AE60-77F26059C799Q34057627-885300D9-5D1E-4606-965C-763949CD41ABQ34190577-7C558DEF-7DAD-4AAF-A95D-3C89750EDA8DQ34347141-2D2E9B27-7BEC-4CF7-A498-A15789A35C02Q34375562-7229FBCD-2315-4731-A474-E3171AE0EC74Q34618728-D9076B9B-9B7C-4902-95E5-1ADE633890AEQ34717215-B2803B01-4D4D-4C5B-8576-409EEF8BEDE6Q35098707-D92F3221-2E6B-487F-97A2-BF627DACD88CQ35261325-76DDC382-CB86-4385-A4AF-1CA27F3D6834Q35568410-9178BF22-AF2A-4ADB-A66A-5D3EAC6CB3E5Q35883639-DDD0C7F2-4940-4093-AACA-41F268746C25Q36176585-536EAB1D-8F95-4F2B-B87E-7091CCFF8A30Q36209190-293ECAF4-6F1C-4DCC-8FDD-DECB492AE65BQ36221367-03FE8EF4-CB00-4B31-B7E9-975F2816ED60Q36221386-0C223EF8-4D49-4385-A405-BEBEE16D2C5BQ36318145-0C3499DF-7FA6-401A-9300-5D4B3F5B101CQ36318156-D054D957-D54A-43CF-A3A8-523907FACDAAQ36378886-1804CB9E-19D1-4363-B17E-27B0F8A49B55Q36541174-84D58C7B-6DF2-4060-8ED2-6B476C54AAA2Q36594178-8EA6DE4D-2E8E-4385-818C-0465ABD82C3DQ36880005-36A32FAE-FBA6-427C-91E5-8E2E55014426Q37099738-43216991-86ED-46DC-A70B-75A45BC468E0Q37110631-1ADB8BB8-8B59-4950-B6C1-A96109B66475Q37123506-A7CF6CA7-B9B5-4739-B5C6-DC46D64E3CA3Q37185117-BDE23E0E-62EC-4572-BF94-7DDF841B98E8Q37185367-35545407-AD73-4BE7-B990-FC92B142286EQ37254362-E542383D-C1E9-48E1-B54A-08E28E0643A9Q37293675-CD54115E-03A4-4AEF-8A49-D5857E76A7E5Q37307520-B0AE81F2-B977-411B-B5F7-937656FBFFADQ37322648-F375F0BB-FEDC-442E-8E3E-4C62CE43D064Q37409025-DE73BF3F-A595-43E7-9BF5-D80002DE4A38
P2860
Functions and mechanisms of action of the adenovirus E3 proteins.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Functions and mechanisms of action of the adenovirus E3 proteins.
@ast
Functions and mechanisms of action of the adenovirus E3 proteins.
@en
type
label
Functions and mechanisms of action of the adenovirus E3 proteins.
@ast
Functions and mechanisms of action of the adenovirus E3 proteins.
@en
prefLabel
Functions and mechanisms of action of the adenovirus E3 proteins.
@ast
Functions and mechanisms of action of the adenovirus E3 proteins.
@en
P2093
P2860
P1476
Functions and mechanisms of action of the adenovirus E3 proteins.
@en
P2093
Ann E Tollefson
Drew L Lichtenstein
Karoly Toth
Konstantin Doronin
William S M Wold
P2860
P304
P356
10.1080/08830180490265556
P577
2004-01-01T00:00:00Z